B4GALNT4 siRNA (Human)
SiRNA to inhibit B4GALNT4 expression using RNA interference
Product Specifications
Product Name Alternative
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1; NGalNAc-T1; Beta-1.4-N-acetylgalactosaminyltransferase IV; Beta4GalNAc-T4; Beta4GalNAcT4
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human B4GALNT4 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
B4GALNT4 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
B4GALNT4
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q76KP1
Entrez GeneHuman
338707
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15207471 1 Vial
Lentiviral mouse Mfsd9 shRNA (UAS) - Lentiviral mouse Mfsd9 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details MBS6320034-01 0.2 mL
MED6, CT (MED6, ARC33, Mediator of RNA polymerase II transcription subunit 6, Activator-recruited cofactor 33kD component, Mediator complex subunit 6, Renal carcinoma antigen NY-REN-28) (AP)
Sign In for Pricing
View Details